co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Nomura said that the CV upcycle is gathering pace, adding that dealers suggested that sectors such as cement, steel, e-commerce and autos are driving demand.
Nivolumab, launched at one-fourth the price of the original drug, is one of the most widely inhibitors used in treating various cancer types including lung, melanoma, kidney and Hodgkin lymphoma
Motilal sees the risk of Eternal being drawn into a 'dogfight', with lower minimum order values and higher discounts amid intensifying competition.
The market is divided between those viewing corrections as buying opportunities and those warning of overheated conditions, an analyst said.
Bank of India shares gained nearly 7% to trade at Rs 168.4 apiece, the highest level seen by the stock since January 2018.
From January 1, investors should expect negligible sales from Revlimid, CFO MV Narasimham tells Moneycontrol. In Q3, US revenues slipped by $35 million sequentially primarily due to lower Revlimid contributions
The shares of these export-oriented companies had significantly declined earlier after the Trump administration increased tariffs on Indian imports to a whopping 50 percent, citing New Delhi's continued purchase of Russian oil.
Gold ETFs also staged a partial recovery, with today’s top loser Birla Sun Life Gold ETF recovering around 6% from its day’s low.
Hindustan Zinc shares tumbled 6% today amid the sharp fall in silver prices.
The company, which showcased its electric cars in India in 2025 and began commercial sales in the second half of the year, is moving into the next phase of growth alongside its parent, Vin Group
PhonePe IPO | The public issue comprises of entirely an offer-for-sale of 5.06 crore equity shares by existing shareholders including promoter WM Digital Commerce Holdings, with no fresh issue component.
Under the renewed strategy, ORSL will exclusively serve as the company’s oral rehydration solutions (ORS) brand built on the WHO‑recommended formula, and will continue to be sold in ready‑to‑drink and powder formats targeting diarrheal dehydration.
Aman Mehta, Managing Director of Torrent Pharma, has been appointed Managing Director of JB Pharma for a three‑year term.
Dr Reddy's, one of India's top three drugmakers by revenue, has been boosting its India business with new product launches and collaborations across therapy areas.
Tata Communications Q3 Results: Data revenue grew 9.3% YoY at Re 5359 crore from Rs 4,903 crore.
In such uncertain phases, investors should avoid panic selling, except in illiquid, loss-making or very small microcap stocks, says a market analyst
Shadowfax IPO GMP: The Bengaluru-based technology-led logistics solutions provider aims to raise Rs 1,907.2 crore through its initial public offering.
UltraTech’s cement volumes are expected to grow around 15–21 percent year-on-year in Q3FY26, led by consolidation of acquired assets and ramp-up of new capacities, according to brokerages.
Deliberations are at an early stage, and details including the valuation and size of the offering could change, the people said.
Globally stock markets are down and the flight to the safety of gold is up as there is a risk-off sentiment in response to Trump’s Greenland policy, the threatened tariffs on eight European countries and Europe’s hardening anti-Trump stance.
Q3 Results: Around 59 companies are announcing their results for the October-December quarter of the ongoing financial year 2026 today.
Some brokerages remained optimistic and increased their target prices for the Persistent Systems shares, while some cited valuation concerns.
Amagi Media Labs share price: The weak listing comes despite the firm’s Rs 1,789-crore IPO being subscribed 30x from January 13-16.
Arohan Financial Services plans to diversify into secured products like gold loans and loans against property.
EAAA India Alternatives IPO | The IPO comprises of entirely offer-for-sale by promoter Edelweiss Securities and Investments, with no fresh issue component.
